株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ウェアラブル除細動器市場:症状(周産期心筋症、先天性心疾患、遺伝性不整脈)、エンドユーザー、地域別の予測

Wearable Cardioverter Defibrillator Market: By Medical Condition (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias); By End User (Hospitals, Home Care, Cardiology Clinics) & By Region-Forecast 2019-2024

発行 IndustryARC 商品コード 422727
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.62円で換算しております。
Back to Top
ウェアラブル除細動器市場:症状(周産期心筋症、先天性心疾患、遺伝性不整脈)、エンドユーザー、地域別の予測 Wearable Cardioverter Defibrillator Market: By Medical Condition (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias); By End User (Hospitals, Home Care, Cardiology Clinics) & By Region-Forecast 2019-2024
出版日: 2018年12月28日 ページ情報: 英文
概要

当レポートでは、世界のウェアラブル除細動器市場について調査し、市場の動向と戦略的分析、症状別、エンドユーザー別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 ウェアラブル除細動器市場:概要

第2章 エグゼクティブサマリー

第3章 市場環境

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーキング
  • エンドユーザープロファイリング
  • 上位5社の財務分析

第4章 市場の力

  • 促進因子
  • 阻害因子
  • 機会
  • 課題
  • ポーターズファイブフォース分析

第5章 戦略的分析

  • バリューチェン分析
  • 価格分析
  • 機会分析
  • 製品/市場ライフサイクル分析
  • 供給者と販売業者

第6章 症状別

  • 周産期心筋症
  • 先天性心疾患
  • 遺伝性不整脈

第7章 エンドユーザー別

  • 病院
  • 在宅ケア
  • 心臓病クリニック

第8章 地域別市場

  • 欧州
  • アジア太平洋地域
  • 北米
  • その他

第9章 エントロピー

  • 拡大
  • 技術的発展
  • 合併・買収、合弁
  • 供給 - 契約

第10章 企業プロファイル

第11章 付録

目次

Wearable cardioverter defibrillator (WCD) is a medical device worn by cardiac patients who are at risk for sudden cardiac arrest (SCA). A wearable cardioverter defibrillator allows their physician time to assess their long-term arrhythmic risk and make appropriate plans for preventing sudden cardiac arrest resulting in a fatality. Globally, an increasing number of people with cardiac diseases and technological advancement in cardiology are expected to remain the key growth drivers for the wearable cardioverter defibrillator during the period of study.

Geographically, North America dominated the wearable cardioverter defibrillator market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the wearable cardioverter defibrillator market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the wearable cardioverter defibrillator market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the wearable cardioverter defibrillator market.

This report segments the wearable cardioverter defibrillator market on the basis of medical condition, end-user and regional market as follows:

Wearable cardioverter defibrillator market research report is classified on the basis of medical condition. Some of the major medical conditions covered in this report are as follows: Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias

Wearable cardioverter defibrillator market research report is classified on the basis of end-user. Some of the major end-users covered in this report are as follows: Hospitals, Home Care, Cardiology Clinics

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the wearable cardioverter defibrillator market. Some of the major companies' profiles in detail are as follows:

ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)

Access Cardio Systems

BIOTRONIC SE & Co. KG

Boston Scientific Corporation

Cardiac Science Corporation

Table of Contents

1. Wearable cardioverter defibrillator Market - Overview

2. Executive Summary

3. Wearable cardioverter defibrillator Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Wearable cardioverter defibrillator Market- Forces

  • 4.1. Drivers
    • 4.1.1. Technological advancement in cardiology
    • 4.1.2. Increasing population with cardiac diseases
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Wearable cardioverter defibrillator Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Wearable cardioverter defibrillator Market, By Medical Condition

  • 6.1. Peripartum Cardiomyopathy
  • 6.2. Congenital Heart Disease
  • 6.3. Inherited Arrhythmias

7. Wearable cardioverter defibrillator Market, By End-User

  • 7.1. Hospitals
  • 7.2. Home Care
  • 7.3. Cardiology Clinics

8. Wearable cardioverter defibrillator Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Wearable cardioverter defibrillator Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
  • 10.2. Access Cardio Systems
  • 10.3. BIOTRONIC SE & Co. KG
  • 10.4. Boston Scientific Corporation
  • 10.5. Cardiac Science Corporation
  • 10.6. Defibtech LLC
  • 10.7. GE Healthcare
  • 10.8. HeartSine Technologies
  • 10.9. Medtronic Inc
  • 10.10. Nihon Kohden corporation
  • 10.11. Phillips Healthcare

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top